[1] |
ZHANG Wei, ZHANG Zhen, LIU Dong, JIANG Houzhou, LIANG Wei.
Comparison of adverse reactions and effects of IMRT combined with different chemotherapy regimens in patients with early stage esophageal squamous cell carcinoma
[J]. Basic & Clinical Medicine, 2024, 44(7): 1018-1022.
|
[2] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
[3] |
LI Tianyi, ZHANG Wenqian, CHEN Yinghan, ZHOU Yue, CUI Yunying, WANG Yu, TONG Anli.
Association of NSE level with clinical features in pheochromocytoma/paraganglioma
[J]. Basic & Clinical Medicine, 2024, 44(4): 533-538.
|
[4] |
LI Jiangli, SUN Jing, TANG Yijun, GUO Junlan, CHEN Bo, GUO Shengnan.
Circ-DDX5 inhibits the proliferation and invasion of human breast cancer cell lines by targeting miR-3940
[J]. Basic & Clinical Medicine, 2024, 44(1): 1-7.
|
[5] |
HUANG Jie, LI Runbo, GUO Jianxin, HAN Jian.
Expression of DDX5 and DDX17 in ovarian cancer tissues and their effects on proliferation and drug resistance of human ovarian cancer cell line SKOV3
[J]. Basic & Clinical Medicine, 2023, 43(8): 1247-1253.
|
[6] |
WANG Jihui, CAO Jilie, ZHANG Lijun, ZHANG Jun, LU Wenbao.
TARBP2 promotes human breast cancer cell metastasis by degrading AKAP12 transcript
[J]. Basic & Clinical Medicine, 2023, 43(8): 1259-1264.
|
[7] |
TANG Yijun, WANG Wenlong, LI Jiangli, YANG Huan, SUN Jing.
LncRNA RP11-686D22.10 is related with the survival of breast cancer patients, affects the proliferation, invasion of breast cancer cell lines
[J]. Basic & Clinical Medicine, 2023, 43(7): 1023-1029.
|
[8] |
JIN Xiaoxia, LU Xiaoyun, LIU Yushan, LIANG Lina.
Expression and clinical significance of SIRT2 in urothelial bladder cancer and its impact on cancer cell proliferation, invasion and migration
[J]. Basic & Clinical Medicine, 2023, 43(7): 1090-1096.
|
[9] |
ZENG Yankun, HONG Xiaoying, CHEN Qinglin.
Down-regulation of BECN1 inhibits the proliferation, invasion and migration of human leukemia cell line THP-1
[J]. Basic & Clinical Medicine, 2023, 43(7): 1104-1109.
|
[10] |
TIAN Yan, MA Jiaojiao, XI Xuehua, ZHANG Bo.
Progress in evaluation of cervical metastatic lymph nodes of differentiated thyroid cancer with ultrasonography
[J]. Basic & Clinical Medicine, 2023, 43(3): 505-508.
|
[11] |
LENG Haina, ZHANG Yan, WANG Xiaodong, ZHANG Xueyou, LI Hongli.
miR-767-5p inhibits the invasion of ovarian cancer cell lines by regulating the expression of TBL1XR1 protein
[J]. Basic & Clinical Medicine, 2023, 43(3): 408-414.
|
[12] |
XU Qian, DUAN Hua, GAN Lu, LIU Qiwei.
Research progress of RhoGTPase activating protein in epithelial-mesenchymal transition
[J]. Basic & Clinical Medicine, 2023, 43(2): 301-305.
|
[13] |
TAN Shufen, YANG Xielan, YANG Linlin, LI Shuqing.
Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer
[J]. Basic & Clinical Medicine, 2023, 43(12): 1861-1865.
|
[14] |
LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao.
The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H
[J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.
|
[15] |
HOU Lijie, MA Chengxu, WANG Jingyu, TANG Xulei, FU Songbo.
LncRNA (HOTAIR) /miR-206/TAGLN2 signal axis regulates the invasion of papillarythyroid carcinoma cells
[J]. Basic & Clinical Medicine, 2023, 43(11): 1642-1647.
|